On August 26, 2024, KLF, in partnership with its co-counsel, filed a class action lawsuit in United States District Court, Northern District of Georgia, against Home Depot, Inc. alleging that the Administrative Committee of The Home Depot FutureBuilder employee benefit plan violated the Employee Retirement Income Security Act (ERISA).

The class action claims that the Administrative Committee failed to act in the best interests of plan participants by using unvested portions of participants’ accounts—commonly referred to as “forfeitures”—to offset the company’s own contributions rather than applying these funds to reduce plan expenses for participants.

The Home Depot Defendants filed a motion to dismiss the complaint, claiming that they have not violated the provisions of ERISA.  The briefing is complete, and the motion is currently pending before the Court.

Please click 2023 Home Depot FutureBuilder Form 5500 Annual Return/Report of Employee Benefit Plan for more information about the employee benefit plan.

Questions About the Home Depot FutureBuilder ERISA Lawsuit?

If you are a participant in the Home Depot FutureBuilder employee benefit plan and have questions or concerns about the lawsuit or your legal options, please contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected] for a free, no-obligation evaluation of potential legal claims.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a multidisciplinary, plaintiff-side class action law firm specializing in securities fraud, breaches of fiduciary duties, and corporate misconduct. The firm’s partners have collectively served as Lead Counsel or Co-Lead Counsel in high-profile cases, recovering over $10 billion for institutional and individual investors.

Kehoe Law Firm, P.C. and its co-counsel successfully secured a derivative settlement with the Dollar Tree Defendants in 2024, addressing critical product and workplace safety failures at Dollar Tree and its subsidiary, Family Dollar.

Following months of negotiations, the settlement resulted in significant corporate governance reforms, including enhanced Board-level oversight of safety measures through quarterly and semi-annual reporting and the creation of a Chief Compliance Officer position.

Michael Yarnoff, a Partner at Kehoe Law Firm, emphasized the importance of these reforms, stating, “Dollar Tree’s reforms will help protect the company from substantial liability, such as the recent $42 million fine and guilty plea by Family Dollar for food safety violations at its warehouses. These long-overdue changes will strengthen the company’s commitment to safety and compliance.”

Questions About the Settlement?

Please address any questions or concerns about the settlement or the litigation to Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a multidisciplinary, plaintiff-side class action law firm specializing in securities fraud, breaches of fiduciary duties, and corporate misconduct. The firm’s partners have collectively served as Lead Counsel or Co-Lead Counsel in high-profile cases, recovering over $10 billion for institutional and individual investors.

On January 15, 2025, Judge J. Paul Oetken denied Defendants’ motion to dismiss, marking a resounding win for our client, Southeastern Pennsylvania Transportation Authority (“SEPTA”), and the class members that SEPTA seeks to represent.  Judge Oetken found that SEPTA’s complaint properly alleged antitrust and unjust enrichment claims.

Notably, Judge Oetken found that SEPTA properly alleged that between 2010 and 2014, the Defendants—nine large Mexican banks—colluded to sell Mexican Government Bonds (“MGB”) at artificially high prices.  He referenced numerous chatroom transcripts alleged within the complaint that showed the improper communications between the Defendants to explicitly discuss and coordinate MGB prices.  He also considered statistical data that showed increased bid-ask spreads and price inflation in the MGB secondary market.

Judge Oetken found the complaint set forth allegations that “read as explicit agreements between Defendants to raise the price of certain MGBs in concert,” and adequately allege the existence of a conspiracy in violation of the Sherman Act.

Further, he found that SEPTA and the other Plaintiffs “have shown that they experienced an antitrust injury and that they are the proper parties to bring this enforcement suit” and that while investment contracts must have existed between Plaintiffs and Defendants for the MGBs exchanged, because such contracts would not “clearly cover … whether Defendants were permitted to collude on MGB resale prices in the secondary market,” the unjust enrichment claims may also proceed.

Importantly, he also found that the statute of limitations was tolled due to Defendants’ fraudulent concealment, as the conspiracy was inherently secret and only became apparent after regulatory investigations were announced.

This decision occurs after an earlier partial $20.7 million settlement was reached with various affiliates of Barclays and JPMorgan Chase & Co., which required their cooperation against the non-settling Defendants.

More information on that partial settlement is available by clicking here:

We look forward to continuing to prosecute this case on behalf of SEPTA and class members.

Questions About the Mexican Government Bonds Antitrust Class Action Lawsuit?

To learn more about the class action lawsuit, please contact John Kehoe, Esq., (215) 792-6676, Ext. 801, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a multidisciplinary, plaintiff-side class action law firm specializing in securities fraud, breaches of fiduciary duties, and corporate misconduct. The firm’s partners have collectively served as Lead Counsel or Co-Lead Counsel in high-profile cases, recovering over $10 billion for institutional and individual investors.

On February 7, 2025, Kehoe Law Firm, P.C. filed a class action lawsuit in U.S. District Court for the Central District of California (Case No. 2:25-cv-01099) on behalf of C&M Pharmacy Inc., d/b/a Parvin’s Pharmacy and Katz Pharmacy, against GoodRx and several major pharmacy benefit managers (PBMs), including CVS Caremark, Express Scripts, MedImpact, and Navitus.

The lawsuit alleges that these entities conspired to suppress reimbursement rates and impose higher fees on independent pharmacies, threatening their financial viability.

The complaint claims that GoodRx’s “Integrated Savings Program” (“ISP”) collaborates with PBMs to artificially lower generic drug reimbursement rates and increase transaction fees, enriching GoodRx and PBMs at the expense of independent pharmacies. The ISP allegedly uses GoodRx’s pricing algorithm and real-time PBM data so the PBMs can improperly coordinate and determine generic drug prices. These actions, according to the lawsuit, violate antitrust laws by fixing prices and creating unfair competition.

“We are pleased to stand with independent pharmacies in their fight against what we believe are the predatory practices of PBMs and GoodRx,” said John Kehoe, Partner at Kehoe Law Firm. “Combating collusion in the healthcare industry is critical to ensuring fair competition and protecting the backbone of many communities—their local pharmacies.”

The Federal Trade Commission (“FTC”) has also been investigating the role of PBMs in the pharmaceutical supply chain. An interim report released in July 2024 raised concerns about PBMs’ vertical integration and market concentration, which have granted PBMs significant control over drug pricing and accessibility. The FTC found that the six largest PBMs manage nearly 95% of all U.S. prescriptions, profiting at the expense of patients and independent pharmacies.

In addition, the House Committee on Oversight and Accountability released a report in July 2024 criticizing the pricing tactics of the three largest PBMs—CVS Caremark, Express Scripts, and OptumRx. The report concluded that these PBMs have monopolized the pharmaceutical market, raising prescription drug prices, undermining community pharmacies, and harming patients nationwide.

Questions About the Antitrust Class Action Lawsuit?

To learn more about the class action lawsuit or discuss potential legal claims, please contact John Kehoe, Esq., (215) 792-6676, Ext. 801, [email protected], [email protected], for a free, no-obligation legal evaluation.

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a multidisciplinary, plaintiff-side class action law firm specializing in securities fraud, breaches of fiduciary duties, and corporate misconduct. The firm’s partners have collectively served as Lead Counsel or Co-Lead Counsel in high-profile cases, recovering over $10 billion for institutional and individual investors.